3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
5
Lung Neoplasms
5
Breast Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Lymphatic Metastasis
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Breast Cancer Lymphedema
2
Brain Neoplasms
2
Vulvar Neoplasms
1
Uterine Neoplasms
1
Solid Tumor
1
Sarcoma, Ewing
1
Right Hemicolectomy
1
Rhabdomyosarcoma
1
Parathyroid Diseases
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Mixed Tumor, Mesodermal
1
Mesothelioma, Malignant
1
Melanoma
1
Margins of Excision
1
Lymphoma
1
Inflammatory Breast Neoplasms
1
Giant Cell Tumor of Tendon Sheath
1
Interventions
durvalumab
13
Bevacizumab
11
Nivolumab
10
tremelimumab
7
pembrolizumab
6
lenvatinib
6
fludarabine
6
Cyclophosphamide
6
atezolizumab
4
Radiosurgery
4
Cisplatin
4
toripalimab
3
relatlimab
3
Magnetic Resonance Imaging
3
Ipilimumab
3
Gemcitabine
3
X-Rays
2
Standard of Care
2
Sorafenib
2
Riluzole
2
Radiotherapy
2
Photons
2
Patient Navigation
2
Lidocaine
2
Hepatectomy
2
Dexamethasone
2
Biopsy
2
trastuzumab deruxtecan
1
tocilizumab
1
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Indocyanine Green
×
1 year
×
Clear all
No trials found.